share_log

4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari

4: Statement of changes in beneficial ownership of securities-Officer Gallman Cari

4:持股變動聲明-高管 Gallman Cari
美股sec公告 ·  08/05 18:02
Moomoo AI 已提取核心訊息
On August 1, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), engaged in a transaction involving the company's common stock. Gallman executed a sale of 384 shares at a price of $48.17 per share, resulting in a total transaction value of $18,497.28. This sale was part of a transaction coded 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. Additionally, Gallman acquired 1,061 shares through an exercise or conversion of derivative security, coded 'M', at no cost. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 2,109 shares.
On August 1, 2024, Cari Gallman, EVP of Corporate Affairs at Bristol-Myers Squibb (BMY), engaged in a transaction involving the company's common stock. Gallman executed a sale of 384 shares at a price of $48.17 per share, resulting in a total transaction value of $18,497.28. This sale was part of a transaction coded 'F', typically indicating a payment of exercise price or tax liability by delivering or withholding securities. Additionally, Gallman acquired 1,061 shares through an exercise or conversion of derivative security, coded 'M', at no cost. Following these transactions, Gallman's direct holdings in Bristol-Myers Squibb common stock amounted to 2,109 shares.
2024年8月1日,施貴寶(BMY)企業事務高級執行副總裁Cari Gallman進行了一筆涉及公司普通股的交易。 Gallman以48.17美元的價格每股出售了384股,交易總價值爲18,497.28美元。此次銷售是交易代碼爲“F”的一部分,通常表示通過交付或扣留證券支付行權價格或納稅義務。此外,Gallman通過行權或轉換衍生證券以零成本編碼爲“M”獲得了1,061股。這些交易後,Gallman在施貴寶普通股中的直接持股數量爲2,109股。
2024年8月1日,施貴寶(BMY)企業事務高級執行副總裁Cari Gallman進行了一筆涉及公司普通股的交易。 Gallman以48.17美元的價格每股出售了384股,交易總價值爲18,497.28美元。此次銷售是交易代碼爲“F”的一部分,通常表示通過交付或扣留證券支付行權價格或納稅義務。此外,Gallman通過行權或轉換衍生證券以零成本編碼爲“M”獲得了1,061股。這些交易後,Gallman在施貴寶普通股中的直接持股數量爲2,109股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息